glutathione conjugation enzyme Metabolism - an overview Color:Buy 10 get 12 free Hide_product L-Glutathion 500mg 100 St

glutathione conjugation enzyme Metabolism - an overview Color:Buy 10 get 12 free Hide_product L-Glutathion 500mg 100 St

L-Glutathion 500mg 100 St Warnke Vitalstoffe bei kaufen

I went back out to have another look

Hide_product

Color:Buy 10 get 12 free

PHYSIOLOGICAL COOLING AGENTS [0095] The compositions may also contain one or more substances with a physiological cool ing effect (cooling agents), which are preferably selected here from the following list: menthol and menthol derivatives (for example L-menthol, D-menthol, racemic menthol, isomenthol, neoisomenthol, neomenthol) menthylethers (for example (l-menthoxy)-l,2-propandiol, (I- menthoxy)-2-methyl-l,2-propandiol, l-menthyl-methylether), menthone glyceryl acetal, men- thone glyceryl ketal or mixtures of both, menthylesters (for example menthylformiate, menthylacetate, menthylisobutyrate, menthyhydroxyisobutyrat, menthyllactates, L-menthyl- L-lactate, L-menthyl-D-lactate, menthyl-(2-methoxy)acetate, menthyl-(2-methoxyethoxy)ace- tate, menthylpyroglutamate), menthylcarbonates (for example menthylpropyleneglycolcar- bonate, menthylethyleneglycolcarbonate, menthylglycerolcarbonate or mixtures thereof), the semi-esters of menthols with a dicarboxylic acid or derivatives thereof (for example mono- menthylsuccinate, mono-menthylglutarate, mono-menthylmalonate, O-menthyl succinic acid ester-N,N-(dimethyl)amide, O-menthyl succinic acid ester amide), menthanecarboxylic acid amides (in this case preferably menthanecarboxylic acid-N-ethylamide [WS3] or N a -(men- thanecarbonyl)glycinethylester [WS5], as described in US 4,150,052, menthanecarboxylic acid-N-(4-cyanophenyl)amide or menthanecarboxylic acid-N-(4-cyanomethylphenyl)amide as described in WO 2005 049553 Al, menthanecarboxylic acid-N-(alkoxyalkyl)amides), men thone and menthone derivatives (for example L-menthone glycerol ketal), 2,3-dimethyl-2-(2- propyl)-butyric acid derivatives (for example 2,3-dimethyl-2-(2-propyl)-butyric acid-N-methyl- amide [WS23]), isopulegol or its esters (l-(-)-isopulegol, l-(-)-isopulegolacetate), menthane de rivatives (for example p-menthane-3,8-diol), cubebol or synthetic or natural mixtures, con taining cubebol, pyrrolidone derivatives of cycloalkyldione derivatives (for example 3-methyl- 2(l-pyrrolidinyl)-2-cyclopentene-l-one) or tetrahydropyrimidine-2-one (for example iciline or related compounds, as described in WO 2004/026840), further carboxamides (for example N- (2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide or related compounds), (lR,2S,5R)-N-(4- Methoxyphenyl)-5-methyl-2-(l-isopropyl)cyclohexane-carboxamide [WS12], oxamates (pref erably those described in EP 2033688 A2) and [(lR,2S,5R)-2-isopropyl-5-methyl-cyclohexyl] 2- (ethylamino)-2-oxo-acetate (X Cool)